GENELUX CORP (GNLX) Fundamental Analysis & Valuation

NASDAQ:GNLX • US36870H1032

Current stock price

2.52 USD
-0.02 (-0.79%)
Last:

This GNLX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GNLX Profitability Analysis

1.1 Basic Checks

  • In the past year GNLX has reported negative net income.
  • In the past year GNLX has reported a negative cash flow from operations.
  • In the past 5 years GNLX always reported negative net income.
  • GNLX had a negative operating cash flow in each of the past 5 years.
GNLX Yearly Net Income VS EBIT VS OCF VS FCFGNLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • The Return On Assets of GNLX (-127.56%) is worse than 80.43% of its industry peers.
  • Looking at the Return On Equity, with a value of -171.45%, GNLX is doing worse than 67.44% of the companies in the same industry.
Industry RankSector Rank
ROA -127.56%
ROE -171.45%
ROIC N/A
ROA(3y)-93.9%
ROA(5y)-116.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GNLX Yearly ROA, ROE, ROICGNLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

  • GNLX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GNLX Yearly Profit, Operating, Gross MarginsGNLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -100K -200K -300K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. GNLX Health Analysis

2.1 Basic Checks

  • GNLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for GNLX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GNLX Yearly Shares OutstandingGNLX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
GNLX Yearly Total Debt VS Total AssetsGNLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • GNLX has an Altman-Z score of -8.33. This is a bad value and indicates that GNLX is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -8.33, GNLX is doing worse than 70.93% of the companies in the same industry.
  • GNLX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.33
ROIC/WACCN/A
WACC9.55%
GNLX Yearly LT Debt VS Equity VS FCFGNLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • GNLX has a Current Ratio of 4.20. This indicates that GNLX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.20, GNLX is in line with its industry, outperforming 49.42% of the companies in the same industry.
  • A Quick Ratio of 4.20 indicates that GNLX has no problem at all paying its short term obligations.
  • GNLX has a Quick ratio (4.20) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.2
Quick Ratio 4.2
GNLX Yearly Current Assets VS Current LiabilitesGNLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. GNLX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 9.38% over the past year.
EPS 1Y (TTM)9.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 36.37% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y10.66%
EPS Next 2Y11.53%
EPS Next 3Y32.43%
EPS Next 5Y36.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GNLX Yearly Revenue VS EstimatesGNLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
GNLX Yearly EPS VS EstimatesGNLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

1

4. GNLX Valuation Analysis

4.1 Price/Earnings Ratio

  • GNLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GNLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNLX Price Earnings VS Forward Price EarningsGNLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNLX Per share dataGNLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

  • GNLX's earnings are expected to grow with 32.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.53%
EPS Next 3Y32.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GNLX Dividend Analysis

5.1 Amount

  • No dividends for GNLX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GNLX Fundamentals: All Metrics, Ratios and Statistics

GENELUX CORP

NASDAQ:GNLX (4/23/2026, 4:30:01 PM)

2.52

-0.02 (-0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-19
Earnings (Next)05-13
Inst Owners29.83%
Inst Owner Change0.08%
Ins Owners10.74%
Ins Owner Change-1.38%
Market Cap112.92M
Revenue(TTM)N/A
Net Income(TTM)-31.87M
Analysts81.67
Price Target17.85 (608.33%)
Short Float %7.84%
Short Ratio15.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.84%
Min EPS beat(2)2.89%
Max EPS beat(2)8.8%
EPS beat(4)3
Avg EPS beat(4)-3.22%
Min EPS beat(4)-39.67%
Max EPS beat(4)15.1%
EPS beat(8)4
Avg EPS beat(8)-9.52%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.48%
PT rev (3m)-9.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.65%
EPS NY rev (1m)0.16%
EPS NY rev (3m)0.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.07
P/tB 6.07
EV/EBITDA N/A
EPS(TTM)-0.87
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS0
BVpS0.41
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -127.56%
ROE -171.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-93.9%
ROA(5y)-116.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 315.06%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.2
Quick Ratio 4.2
Altman-Z -8.33
F-Score2
WACC9.55%
ROIC/WACCN/A
Cap/Depr(3y)125.54%
Cap/Depr(5y)76.05%
Cap/Sales(3y)1788.63%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.85%
EPS Next Y10.66%
EPS Next 2Y11.53%
EPS Next 3Y32.43%
EPS Next 5Y36.37%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-53.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.51%
OCF growth 3YN/A
OCF growth 5YN/A

GENELUX CORP / GNLX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GENELUX CORP?

ChartMill assigns a fundamental rating of 2 / 10 to GNLX.


Can you provide the valuation status for GENELUX CORP?

ChartMill assigns a valuation rating of 1 / 10 to GENELUX CORP (GNLX). This can be considered as Overvalued.


How profitable is GENELUX CORP (GNLX) stock?

GENELUX CORP (GNLX) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for GNLX stock?

The Earnings per Share (EPS) of GENELUX CORP (GNLX) is expected to grow by 10.66% in the next year.